280 related articles for article (PubMed ID: 17076881)
1. Long-term consequences of arsenic poisoning during infancy due to contaminated milk powder.
Dakeishi M; Murata K; Grandjean P
Environ Health; 2006 Oct; 5():31. PubMed ID: 17076881
[TBL] [Abstract][Full Text] [Related]
2. Neurological and neuropsychological functions in adults with a history of developmental arsenic poisoning from contaminated milk powder.
Yorifuji T; Kato T; Ohta H; Bellinger DC; Matsuoka K; Grandjean P
Neurotoxicol Teratol; 2016; 53():75-80. PubMed ID: 26689609
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Prospective Study of 6104 Survivors of Arsenic Poisoning During Infancy Due to Contaminated Milk Powder in 1955.
Tanaka H; Tsukuma H; Oshima A
J Epidemiol; 2010; 20(6):439-45. PubMed ID: 20736507
[TBL] [Abstract][Full Text] [Related]
4. Height and blood chemistry in adults with a history of developmental arsenic poisoning from contaminated milk powder.
Yorifuji T; Matsuoka K; Grandjean P
Environ Res; 2017 May; 155():86-91. PubMed ID: 28199894
[TBL] [Abstract][Full Text] [Related]
5. [Excess mortality among 5,064 victims of arsenic poisoning from ingestion of arsenic-contaminated "Morinaga dry-milk" in 1955: a prospective study from 1982 to 2004].
Tanaka H; Oshima A
Nihon Koshu Eisei Zasshi; 2007 Apr; 54(4):236-45. PubMed ID: 17533959
[TBL] [Abstract][Full Text] [Related]
6. Long-term observational study on 6223 survivors of arsenic poisoning due to contaminated milk powder during infancy.
Liu R; Tabuchi T; Kitamura T; Miyashiro I; Sobue T
Cancer Sci; 2020 Oct; 111(10):3873-3880. PubMed ID: 32885537
[TBL] [Abstract][Full Text] [Related]
7. Cancer excess after arsenic exposure from contaminated milk powder.
Yorifuji T; Tsuda T; Doi H; Grandjean P
Environ Health Prev Med; 2011 May; 16(3):164-70. PubMed ID: 21431798
[TBL] [Abstract][Full Text] [Related]
8. [Activities of the organization to protect the victims of poisoning due to arsenic-contaminated milk produced by Morinaga Company].
Inamura A
Hokenfu Zasshi; 1974; 30(9-10):573-8. PubMed ID: 4499294
[No Abstract] [Full Text] [Related]
9. [Interactions between the organization of the arsenic poisoning victims (arsenic-tainted milk produced by Morinaga Company) and the investigating committee].
Koike M
Hokenfu Zasshi; 1974; 30(9-10):576-7. PubMed ID: 4499295
[No Abstract] [Full Text] [Related]
10. Shellfish and residual chemical contaminants: hazards, monitoring, and health risk assessment along French coasts.
Guéguen M; Amiard JC; Arnich N; Badot PM; Claisse D; Guérin T; Vernoux JP
Rev Environ Contam Toxicol; 2011; 213():55-111. PubMed ID: 21541848
[TBL] [Abstract][Full Text] [Related]
11. Arsenic and diabetes: current perspectives.
Huang CF; Chen YW; Yang CY; Tsai KS; Yang RS; Liu SH
Kaohsiung J Med Sci; 2011 Sep; 27(9):402-10. PubMed ID: 21914528
[TBL] [Abstract][Full Text] [Related]
12. Unusual cancer excess after neonatal arsenic exposure from contaminated milk powder.
Yorifuji T; Tsuda T; Grandjean P
J Natl Cancer Inst; 2010 Mar; 102(5):360-1. PubMed ID: 20068193
[No Abstract] [Full Text] [Related]
13. Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan.
Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Chen CJ
Environ Res; 2010 Jul; 110(5):455-62. PubMed ID: 19735913
[TBL] [Abstract][Full Text] [Related]
14. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
[TBL] [Abstract][Full Text] [Related]
15. [Activities of the investigation committee concerning poisoning caused by arsenic-contamination milk produced by the Morinaga Company].
Inamura A
Hokenfu Zasshi; 1974; 30(9-10):600-2. PubMed ID: 4499302
[No Abstract] [Full Text] [Related]
16. Health risk associated with dietary co-exposure to high levels of antimony and arsenic in the world's largest antimony mine area.
Wu F; Fu Z; Liu B; Mo C; Chen B; Corns W; Liao H
Sci Total Environ; 2011 Aug; 409(18):3344-51. PubMed ID: 21684578
[TBL] [Abstract][Full Text] [Related]
17. Arsenic groundwater contamination and its health effects in the state of Uttar Pradesh (UP) in upper and middle Ganga plain, India: a severe danger.
Ahamed S; Kumar Sengupta M; Mukherjee A; Amir Hossain M; Das B; Nayak B; Pal A; Chandra Mukherjee S; Pati S; Nath Dutta R; Chatterjee G; Mukherjee A; Srivastava R; Chakraborti D
Sci Total Environ; 2006 Nov; 370(2-3):310-22. PubMed ID: 16899281
[TBL] [Abstract][Full Text] [Related]
18. Chronic arsenic exposure and its adverse health effects in Taiwan: a paradigm for management of a global environmental problem.
Lan CC; Yu HS; Ko YC
Kaohsiung J Med Sci; 2011 Sep; 27(9):411-6. PubMed ID: 21914529
[TBL] [Abstract][Full Text] [Related]
19. Arsenic-related health problems among hospital patients in southern Bangladesh.
Mitra AK; Bose BK; Kabir H; Das BK; Hussain M
J Health Popul Nutr; 2002 Sep; 20(3):198-204. PubMed ID: 12430755
[TBL] [Abstract][Full Text] [Related]
20. Workshop overview: arsenic research and risk assessment.
Sams R; Wolf DC; Ramasamy S; Ohanian E; Chen J; Lowit A
Toxicol Appl Pharmacol; 2007 Aug; 222(3):245-51. PubMed ID: 17336359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
